Meint Volbeda

Dr. Meint Volbeda is an active Critical Care researcher at the University of Groningen's Faculty of Medical Sciences, specializing in nephrology within the Department of Critical Care. His work focuses on acute kidney injury, sepsis pathophysiology, and renal replacement therapy in intensive care settings.

Research interests center on biomarker development for critical illness, with particular expertise in creatinine clearance/eGFR ratios as mortality predictors, NGAL/cystatin C plasma profiling, and citrate-based anticoagulation for continuous renal replacement therapy. His fingerprint analysis reveals strong contributions to COVID-19 critical care (100%), Acute Kidney Injury (73%), and Sepsis (70%) research domains.

Recent publications demonstrate trends toward precision monitoring in mixed ICU populations and optimization of extracorporeal circuit survival. His 2024 study on creatinine clearance/eGFR ratios gained significant media traction, being covered by news outlets and discussed across 18 X (Twitter) accounts and Bluesky platforms.

Dr. Volbeda actively collaborates within international critical care networks, with research outputs spanning articles, editorials, and datasets. His work contributes to UN Sustainable Development Goals through advancements in critical care medicine and patient outcomes.